RARECast
Un pódcast de RARECast - Jueves
548 Episodo
-
Choosing the Right Viral Vector for a Gene Therapy
Publicado: 1/4/2021 -
A Software Platform to Give Patients the Tools to Build Treatments for Rare Genetic Diseases
Publicado: 25/3/2021 -
Side Effects: The Toll a Rare Disease Can Take on a Family in Pursuit of a Cure
Publicado: 19/3/2021 -
Realizing the Potential of CRISPR Gene Editing
Publicado: 12/3/2021 -
Understanding the Economic Toll of Rare Disease in the United States
Publicado: 4/3/2021 -
The Promise of Gene-Based Therapies for Neurodegenerative Conditions
Publicado: 25/2/2021 -
Moving Beyond Viral Vectors for Gene Therapies
Publicado: 19/2/2021 -
Acquisitions Help Jazz Build Toward Commercial Crescendo
Publicado: 12/2/2021 -
Powerful Gene Editing Approach Offers the Promise of Correcting a Range of Rare Diseases
Publicado: 5/2/2021 -
A Child's-Eye-View of Clinical Trials
Publicado: 29/1/2021 -
Using Nanoliposomes to Make Cancer Therapies Safer and More Effective
Publicado: 21/1/2021 -
Accelerating Treatments for Rare Disease through Data Sharing
Publicado: 14/1/2021 -
Treating the Root Cause of Sickle Cell Disease
Publicado: 8/1/2021 -
Targeting a Common Pathway in Genetic Forms of Obesity
Publicado: 30/12/2020 -
After Pruning Orchard, Gaspar Focuses on High Value Opportunities
Publicado: 23/12/2020 -
Writing a New Chapter of Genetic Medicine
Publicado: 17/12/2020 -
How an Ultra-Rare Disease Patient Organization Drove Research to a Treatment
Publicado: 10/12/2020 -
With a New Identity, Travere Thearpeutics Seeks to Find Its True Path
Publicado: 4/12/2020 -
Making Gene Therapies Accessible to Patient with Ultra-Rare Conditions
Publicado: 26/11/2020 -
Using RNA Therapies to Target Inherited Retinal Diseases
Publicado: 20/11/2020
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.
